G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 10, 2023 at 05:34 am EST
Share
G&E Herbal Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 47.35 million compared to TWD 19.63 million a year ago. Net income was TWD 22.23 million compared to TWD 5.75 million a year ago. Basic earnings per share from continuing operations was TWD 0.4 compared to TWD 0.1 a year ago. Diluted earnings per share from continuing operations was TWD 0.4 compared to TWD 0.1 a year ago.
For the nine months, sales was TWD 132.6 million compared to TWD 34.53 million a year ago. Net income was TWD 53.98 million compared to net loss of TWD 2.17 million a year ago. Basic earnings per share from continuing operations was TWD 0.97 compared to basic loss per share from continuing operations of TWD 0.04 a year ago. Diluted earnings per share from continuing operations was TWD 0.97 compared to diluted loss per share from continuing operations of TWD 0.04 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
